St. Jude Medical ( STJ ) Wednesday delivered record first-quarter revenue driven by strong sales growth in several product groups, and offered strong second-quarter earnings guidance.

The Minnesota-based company had net income of $95.7 million, or 52 cents a share, vs. $80 million, or 43 cents a share, a year ago, The consensus estimate was for 50 cents a share, according to Thomson First Call.

Revenue jumped 24% in the period to $548.6 million, led by sales of its implantable cardioverter defibrillators, pacemakers and vascular closure devices.

The company expects EPS of 52 cents to 54 cents a share in the second quarter and $2.18 to $2.23 for full-year 2004. The consensus forecast is for 50 cents a share and $2.20 a share, respectively.

Shares were recently up $1.74, or 2.3%, to $76.78.

If you liked this article you might like

Spain to Play Netherlands for World Cup

Spain to Play Netherlands for World Cup

Wal-Mart: Analysts' Upgrades, Downgrades

Wal-Mart: Analysts' Upgrades, Downgrades

Netherlands Advances to World Cup Final

Netherlands Advances to World Cup Final

Apple: Analysts' Upgrades, Downgrades

Apple: Analysts' Upgrades, Downgrades

World Markets Mostly Lower Monday

World Markets Mostly Lower Monday